Wave Life Sciences (WVE) Net Margin: 2015-2025
Historic Net Margin for Wave Life Sciences (WVE) over the last 7 years, with Jun 2025 value amounting to -580.17%.
- Wave Life Sciences' Net Margin fell 41298.00% to -580.17% in Q2 2025 from the same period last year, while for Jun 2025 it was -259.21%, marking a year-over-year decrease of 19271.00%. This contributed to the annual value of -89.57% for FY2024, which is 3881.00% down from last year.
- As of Q2 2025, Wave Life Sciences' Net Margin stood at -580.17%, which was down 13.55% from -510.93% recorded in Q1 2025.
- Wave Life Sciences' Net Margin's 5-year high stood at 14.78% during Q3 2023, with a 5-year trough of -13,685.61% in Q3 2022.
- In the last 3 years, Wave Life Sciences' Net Margin had a median value of -189.58% in 2023 and averaged -232.33%.
- Its Net Margin has fluctuated over the past 5 years, first plummeted by 1,366,851bps in 2022, then soared by 1,370,040bps in 2023.
- Wave Life Sciences' Net Margin (Quarterly) stood at -1,970.82% in 2021, then plummeted by 155,694bps to -3,527.76% in 2022, then skyrocketed by 347,174bps to -56.03% in 2023, then slumped by 7,172bps to -167.19% in 2024, then crashed by 41,298bps to -580.17% in 2025.
- Its Net Margin stands at -580.17% for Q2 2025, versus -510.93% for Q1 2025 and -167.19% for Q2 2024.